The cluster is too small relative to market cap to carry a directional signal. The $24.8M in insider buying over the prior 30 days (likely from the IPO lockup expiry or option exercises) dominates this $1.89M sell cluster. Monitor for any C-suite selling or larger director sales exceeding 0.5% of market cap before assigning bearish weight.
Price Chart
Executive Summary
Two CG Oncology directors sold a combined $1.89M in stock over a 7-day window, with the bulk ($1.82M) sold by director James Mulay at $75.16. The total sales represent ~0.03% of the $6.3B market cap, falling well below the 0.1% materiality threshold. Director Leonard Post's sale was a same-day exercise-and-sell of 1,000 shares at $71.17, a routine cashless exercise pattern. The dollar amounts are trivial relative to company size, making this cluster non-informative despite the cross-filing amplifier signals.
Key Financial Metrics
Key Facts
- Director James Mulay sold 24,200 shares for $1.82M at $75.16 on 2026-07-10
- Director Leonard Post sold 1,000 shares for $71,170 at $71.17 on 2026-07-15, after exercising derivatives for $600 and $0
- Total cluster value of $1.89M represents ~0.03% of CGON's $6.3B market cap
- No C-suite executives traded; both sellers are directors
- Recent insider activity (30d) shows $24.8M in buys vs $2.2M in sells, indicating net buying by other insiders
Financial Impact
Total insider sales of $1.89M, or ~0.03% of market cap — immaterial
Risk Factors
- Small sample — only 2 directors sold, no C-suite participation
- Post's sale is a routine cashless exercise (derivative exercise + immediate sale) with no informational content
- Cross-filing amplifier signals are statistically significant but the absolute dollar amount is too small to trigger a materiality override
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CGON-1784354556299 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | Press Release | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | $67.38 (+9.98%) |
Aug 6, 2026 8w ago | 424B5 | $74.85 $74.33 | ▲ +0.69% | ▲ +1.29% | $67.38 (+9.98%) |
Jul 27, 2026 9w ago | Press Release | $72.62 $78.95 | ▲ +8.72% | ▲ +5.34% | $67.38 (−7.22%) |
Jul 17, 2026 11w ago | Insider Cluster | $71.85 $75.03 | ▲ +4.43% | ▼ −0.02% | $67.38 (−6.22%) |
Jul 16, 2026 11w ago | Court Ruling | $69.50 $74.71 | ▲ +7.50% | ▲ +3.88% | $67.38 (−3.05%) |
Jun 24, 2026 14w ago | 144 | $72.84 $71.12 | ▼ −2.36% | ▼ −2.89% | $67.38 (−7.50%) |
Jun 22, 2026 14w ago | 144 | $65.73 $70.19 | ▲ +6.79% | ▲ +5.63% | $67.38 (+2.51%) |
Jun 12, 2026 16w ago | Institutional Cluster | $59.56 $75.24 | ▲ +26.33% | ▲ +24.55% | $67.38 (+13.13%) |
May 26, 2026 18w ago | 8-K | $61.89 $70.25 | ▲ +13.50% | ▲ +15.45% | $67.38 (+8.87%) |
May 15, 2026 20w ago | Press Release | $66.93 $59.56 | ▼ −11.01% | ▼ −13.13% | $67.38 (+0.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access